Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 9:13:2777-2786.
doi: 10.2147/DDDT.S214907. eCollection 2019.

Minoxidil and its use in hair disorders: a review

Poonkiat Suchonwanit  1 , Sasima Thammarucha  1 , Kanchana Leerunyakul  1
Affiliations
Review

Minoxidil and its use in hair disorders: a review

Poonkiat Suchonwanit et al. Drug Des Devel Ther. .

Erratum in

Abstract

Minoxidil was first introduced as an antihypertensive medication and the discovery of its common adverse event, hypertrichosis, led to the development of a topical formulation for promoting hair growth. To date, topical minoxidil is the mainstay treatment for androgenetic alopecia and is used as an off-label treatment for other hair loss conditions. Despite its widespread application, the exact mechanism of action of minoxidil is still not fully understood. In this article, we aim to review and update current information on the pharmacology, mechanism of action, clinical efficacy, and adverse events of topical minoxidil.

Keywords: alopecia; beard; eyebrow; hair loss; hair shaft disorders; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Chemical structure of minoxidil.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Campese VM. Minoxidil: a review of its pharmacological properties and therapeutic use. Drugs. 1981;22(4):257–278. doi:10.2165/00003495-198122040-00001 - DOI - PubMed
    1. Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130–136. - PubMed
    1. Tata S, Weiner N, Flynn G. Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin. J Pharm Sci. 1994;83(10):1508–1510. doi:10.1002/jps.2600831026 - DOI - PubMed
    1. Gogtay JA, Panda M. Minoxidil topical foam: a new kid on the block. Int J Trichology. 2009;1(2):142. doi:10.4103/0974-7753.58560 - DOI - PMC - PubMed
    1. Purnak T, Senel E, Sahin C. Liquid formulation of minoxidil versus its foam formulation. Indian J Dermatol. 2011;56(4):462. doi:10.4103/0019-5154.84714 - DOI - PMC - PubMed